OCS CIK: 1953530

Oculis Holding AG

  • Switzerland
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions CHF
FY21:
48.0
FY22:
23.7
FY23:
101
FY24:
105
FY25:
219
(positive)
Change from FY21 to FY25
millions CHF
FY21:
10.1
FY22:
13.4
FY23:
13.3
FY24:
15.5
FY25:
17.1
Total assets
Change from FY21 to FY25
millions CHF
FY21:
58.0
FY22:
37.1
FY23:
114
FY24:
120
FY25:
236

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions CHF
FY21:
4.06
FY22:
12.0
FY23:
19.1
FY24:
44.2
FY25:
36.7
(negative)
Change from FY21 to FY25
millions CHF
FY21:
115
FY22:
123
FY23:
1.54
FY24:
2.74
FY25:
3.15
(positive)
Change from FY21 to FY25
millions CHF
FY21:
−61.0
FY22:
−98.0
FY23:
93.7
FY24:
73.4
FY25:
196
Total liabilities & equity
Change from FY21 to FY25
millions CHF
FY21:
58.0
FY22:
37.1
FY23:
114
FY24:
120
FY25:
236

All amounts in millions CHF Data source:SEC EDGAR